Muscle weakness after sugammadex: incomplete reversal of neuromuscular blockade or delayed postoperative recurarisation?

Br J Anaesth. 2023 Mar;130(3):e409-e412. doi: 10.1016/j.bja.2022.11.016. Epub 2022 Dec 29.

Authors

Bente F H Dubois¹, Jan Fraessdorf¹, Manfred Blobner², Markus W Hollmann³, Elisabeth M J P Mouws¹

Affiliations

¹ Department of Anaesthesiology, Amsterdam UMC, Amsterdam, the Netherlands.
² Department of Anaesthesiology and Intensive Care Medicine, Technical University of Munich, School of Medicine, Munich, Germany; Department of Anaesthesiology and Intensive Care Medicine, Ulm University, Ulm, Germany.
³ Department of Anaesthesiology, Amsterdam UMC, Amsterdam, the Netherlands. Electronic address: m.w.hollmann@amsterdamumc.nl.

PMID: 36586807
DOI: 10.1016/j.bja.2022.11.016

No abstract available

Keywords: neuromuscular blockade; neuromuscular function monitoring; pharmacokinetics; recurarisation; rocuronium; sugammadex; train-of-four.

Publication types

Letter

MeSH terms

Androstanols
Humans
Muscle Weakness / chemically induced
Neuromuscular Blockade*
Rocuronium
Sugammadex
gamma-Cyclodextrins* / pharmacology
gamma-Cyclodextrins* / therapeutic use

Substances

Sugammadex
gamma-Cyclodextrins
Rocuronium
Androstanols